Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunothe...

por Haywood, Sophia, Garioch, Jennifer, Ramaiya, Arjun, Moncrieff, Marc
Publicado 2020

ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB–IIC Patients After 3 Years

por Moncrieff, Marc, Underwood, Beverly, Garioch, Jennifer, Heaton, Martin, Patel, Nakul, Bastiaannet, Esther, Hoekstra-Weebers, Josette, Hoekstra, Harald
Publicado 2020

Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients

por Hussain, Zahra, Heaton, Martin J., Snelling, Andrew P., Nobes, Jenny P., Gray, Gill, Garioch, Jennifer J., Moncrieff, Marc D.
Publicado 2022

A UK feasibility and validation study of the VE1 monoclonal antibody immunohistochemistry stain for BRAF-V600E mutations in metastatic melanoma

por Lo, Michelle Chin I, Paterson, Anna, Maraka, Jane, Clark, Richard, Goodwill, Joseph, Nobes, Jenny, Garioch, Jennifer, Moncrieff, Marc, Rytina, Ed, Igali, Laszlo
Publicado 2016

The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years

por Moncrieff, Marc D., Underwood, Beverly, Garioch, Jennifer J., Heaton, Martin, Patel, Nakul, Bastiaannet, Esther, Hoekstra-Weebers, Josette E. H. M., Hoekstra, Harald J.
Publicado 2020